ino-5401
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 24, 2018 (NCT03502785)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04367675 | Phase 1 | Sep 30, 2020 | Inovio Pharmaceuticals, University of Pennsylvania |
| NCT03491683 | Phase 1/Phase 2 (Phase 2) | May 31, 2018 | Inovio Pharmaceuticals |
| NCT03502785 | Phase 1/Phase 2 (Phase 2) | May 24, 2018 | Inovio Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals | For profit | 3 | 2 | 2 | 2018 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1